India suspended production at Maiden Pharmaceuticals in October last year for violations of manufacturing standards after the World Health Organization said four of its cough syrups may have killed dozens of children in Gambia. The company has denied its drugs were at fault for the deaths in Gambia and tests by an Indian government laboratory found there were no toxins in them.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/8bXwsJL
via IFTTT
0 comments:
Post a Comment